Skip to main content
Log in

Consumer Believability of Information in Direct-to-Consumer (DTC) Advertising of Prescription Drugs

  • Published:
Journal of Business Ethics Aims and scope Submit manuscript

Abstract

Direct to consumer (DTC) advertising has attracted significant research attention, yet none has focused on empirical assessments of its overall impact on U.S. consumers nationally, and tying assessment to relevant behavioral outcomes. This paper addresses the ethical issue of DTC advertising providing a balance of product and risk information that is both understandable and believable, and contributes direction to those exploring this phenomenon.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • AARP: 2000, ‘Are Consumers Well Informed About Prescription Drugs? The Impact of Printed Direct- to-Consumer Advertising’, http://research.aarp.org/health/2000_04_advertising.html.

  • Adams, C.: 2001, ‘FDA Scrambles to Police Drug Ads’ Truthfulness’, Wall Street Journal, January 2, A24.

  • C. J. Andrews R. G. Netemeyer S. Durvasala (1990) ArticleTitle‘Believability and Attitudes Toward Warning Label Information: The Role of Persuasive Communication Theory’ Journal of Public Policy and Marketing 9 1–15

    Google Scholar 

  • C. J. Andrews R. G. Netemeyer S. Durvasala (1991) ArticleTitle‘Effects of Consumption Frequency on Behavior and Attitudes Toward Alcohol Warning Labels’ Journal of Consumer Affairs 25 323–338

    Google Scholar 

  • R. A. Bell R. L. Kravitz M. S. Wilkes (1999) ArticleTitle‘Direct-to-Consumer Prescription Drug Advertising and the Public’ Journal of General Internal Medicine 14 651–657 Occurrence Handle10.1046/j.1525-1497.1999.01049.x

    Article  Google Scholar 

  • R. A. Bell M. S. Wilkes R. L. Kravitz (2000) ArticleTitle‘The Educational Value of Consumer-Targeted Prescription Drug Print Advertising’ Journal of Family Practice 49 1092–1098

    Google Scholar 

  • R. F. Beltramini E. R. Stafford (1993) ArticleTitle‘Comprehension and Perceived Believability of Seals of Approval Information in Advertising’ Journal of Advertising 23 3–13

    Google Scholar 

  • P. S. Cady L. N. Larson (1989) ArticleTitle‘Brief Summary and the Believability of Consumer Prescription Drug Advertising’ Journal of Pharmaceutical Marketing and Management 3 65–72

    Google Scholar 

  • Calfee, J. E.: 2001, ‘What Consumer Surveys Show About Direct-to-Consumer Advertising of Prescription Drugs’, paper prepared for the American Enterprise Institute, May.

  • J. E. Calfee (2002) ArticleTitle‘Public Policy Issues in Direct-to-Consumer Advertising of Prescription Drugs’ Journal of Public Policy and Marketing 21 174–193

    Google Scholar 

  • Castillo, M. and R. Hopkins: 2002, ‘Why DTC Advertising has Failed in the United States and How It Can Succeed’, paper presented at the ESOMAR “Global Healthcare 2” Conference, February; http://www.decisionanalyst.com/publ_art/Physicians.asp.

  • J. B. Cohen (2002) ArticleTitle‘Introductory Comments: Direct-to-Consumer Prescription Drug Advertising: Evaluating Regulatory Policy in the United States and New Zealand’ Journal of Public Policy and Marketing 21 172–173

    Google Scholar 

  • Sandra. Coney (2002) ArticleTitle‘Direct-to-Consumer Advertising of Prescription Pharmaceuticals: A Consumer Perspective from New Zealand’ Journal of Public Policy and Marketing 21 213–223

    Google Scholar 

  • L. A. Foley D. J. Gross (2000) Are Consumers Well Informed About Prescription Drugs? The Impact of Printed Direct-to-Consumer Advertising AARP Public Policy Institute Washington, DC

    Google Scholar 

  • Food and Drug Administration: 1999, ‘Attitudes and Behaviors Associated with Direct-to-Consumer (DTC) Promotion of Prescription Drugs: Main Survey Results’, Center for Drug Evaluation and Research, Division of Drug Marketing, http://www.fda.gov/cder/ddmac/dtcindex.htm.

  • Food and Drug Administration: 2002, ‘Direct-to-Consumer Advertising of Prescription Drugs: Preliminary Patient Survey Results’, Center for Drug Evaluation and Research, Division of Drug Marketing, http://www.fda.gov/cder/ddmac/dtcindex.htm.

  • Frank, R., E. R. Berndt, J. Donohue, A. Epstein and M. Rosenthal: 2002, ‘Trends in Direct-to-Consumer Advertising of Prescription Drugs’, report #3162 prepared by the Kaiser Family Foundation, Washington, DC.

  • F. R. Gates W. D. Hoyer (1985) ArticleTitle‘Measuring Miscomprehension: A Comparison of Alternative Formats’ Advances in Consumer Research 13 143–146

    Google Scholar 

  • Goetzl, D.: 2000, ‘TVB Study: DTC disclosures lend credibility to drug ads’, Advertising Age, June 5, 6.

  • J. Hoek P. Gendall (2002) ArticleTitle‘Direct-to-Consumer Advertising Down Under: An Alternative Perspective and Regulatory Framework’ Journal of Public Policy and Marketing 21 202–212

    Google Scholar 

  • A. J. Huang (2000) ArticleTitle‘The Rise of Direct-to-Consumer Advertising of Prescription Drugs in the United States’ Journal of the American Medical Association 284 2240 Occurrence Handle10.1001/jama.284.17.2240

    Article  Google Scholar 

  • Kaiser Family Foundation: 2001, ‘Understanding the Effects of Direct-to-Consumer Prescription Drug Advertising’, November.

  • M. A. Kamins (1989) ArticleTitle‘Celebrity and Non-Celebrity Advertising in a Two-Sided Context’ Journal of Advertising Research 18 34–42

    Google Scholar 

  • J. Lexchin B. Mintzes (2002) ArticleTitle‘Direct-to-Consumer Advertising of Prescription Drugs: The Evidence Says No’ Journal of Public Policy and Marketing 21 194–201

    Google Scholar 

  • A. Lyles (2002) ArticleTitle‘Direct Marketing of Pharmaceuticals to Consumers’ Annual Reviews of Public Health 23 73–91

    Google Scholar 

  • McInturff, B.: 2001, ‘While critics may fret, public likes DTC ads’, Advertising Age, March 26, 24.

  • L. A. Morris D. Brinberg R. Klimberg C. Rivera L. G. Millstein (1986) ArticleTitle‘The Attitudes of Consumers toward Direct Advertising of Prescription Drugs’ Public Health Reports 101 82–89

    Google Scholar 

  • Multimedia Audience Research Systems: 2002, ‘OTC/DTC Marketing and Media Survey’.

  • InstitutionalAuthorNameNational Consumers League (1998) Health Care Information and the Consumer: A Public Opinion Survey National Consumers League Washington, DC

    Google Scholar 

  • InstitutionalAuthorNameNational Consumers League (2002) Effectiveness and Attitudes toward Medication Advertising National Consumers League Washington, DC

    Google Scholar 

  • National Health Council: 2002, Direct-to-Consumer Prescription Drug Advertising: Overview and Recommendations, January, http://www.nationalhealthcouncil.org/advocacy/DTC_paper.pdf.

  • InstitutionalAuthorNameNational Institute of Health Care Management (2001) Prescription Drugs and Mass Media Advertising NIHCM Washington, DC

    Google Scholar 

  • NewsHour with Jim Lehrer, Kaiser Family Foundation, and Harvard School of Public Health: 2000, National Survey on Prescription Drugs, (Kaiser Family Foundation, Menlo Park, CA).

  • W. L. Pines (1999) ArticleTitle‘A History and Perspective on Direct-to-Consumer Promotion’ Food and Drug Law Journal 54 489–518

    Google Scholar 

  • I. L. Preston J. I. Richards (1993) ArticleTitle‘A Role for Consumer Belief in FTC and Lanham Act Deceptive Advertising Cases’ American Business Law Journal 31 1–29

    Google Scholar 

  • J. I Richards (1990) Deceptive Advertising: Behavioral Study of a Legal Concept Lawrence Erlbaum and Associates Hillsdale, NJ

    Google Scholar 

  • InstitutionalAuthorNameRodale Publications (1999) Prevention Magazine: A National Survey of Consumer Reactions to Direct-to-Consumer Advertising Rodale Publications Emmaus, PA

    Google Scholar 

  • InstitutionalAuthorNameRodale Publications (2000) Prevention Magazine: International Survey on Wellness and Consumer Reactions to DTC Advertising of Rx Drugs Rodale Publications Emmaus, PA

    Google Scholar 

  • InstitutionalAuthorNameRodale Publications (2001–2002) 5th Annual Survey: Consumer Reaction to DTC Advertising of Prescription Medicines Rodale Publications Emmaus, PA

    Google Scholar 

  • “Study shows positive action, attitude from TV drug ads”: 2000, Medical Marketing and Media, 35, 26.

  • N. Sumpradit S. W. Fors L. McCormick (2002) ArticleTitle‘Consumers’ Attitudes and Behavior Toward Prescription Drug Advertising’ American Journal of Health Behaviors 26 68–75

    Google Scholar 

  • InstitutionalAuthorNameTime Inc. (2000) Measuring the Awareness and Impact of Direct-to-Consumer Pharmaceutical Advertising Time Inc. New York

    Google Scholar 

  • InstitutionalAuthorNameU.S. General Accounting Office (2002) Prescription Drugs: FDA Oversight of Direct-to-Consumer Advertising has Limitations U.S. General Accounting Office Washington, DC

    Google Scholar 

  • Weber, J.: 1995, ‘It’s Enough to Make You Sick’, Business Week, September 18, 48.

  • InstitutionalAuthorNameThe Wirthlin Report (1999) March Wirthlin Worldwide McLean, VA

    Google Scholar 

  • S. M. Wolfe (2002) ArticleTitle‘Direct-to-Consumer Advertising: Education or Emotional Promotion?’ New England Journal of Medicine 346 524–526 Occurrence Handle10.1056/NEJM200202143460713

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard F. Beltramini.

Additional information

Richard F. Beltramini is currently Professor of Marketing in the School of Business Administration at Wayne State University. He received his Ph.D. from the University of Texas at Austin, and served on the faculty of Arizona State University for fifteen years. His teaching interests include advertising and marketing management, research, and strategy. His primary research focus is on the believability of marketing communications information, and he has published in the Journal of Advertising, Journal of Advertising Research, Journal of Consumer Research, Journal of Marketing, and a variety of other journals, conference proceedings, and books as well as co-editing Gift Giving: A Research Anthology. Dr. Beltramini has served on the Editorial Review Boards of a number of academic journals, as guest editor of special issues of the Journal of Business Ethics and the International Journal of Internet Marketing and Advertising, as international president of the American Academy of Advertising, as a member of the American Advertising Federation's National Academic Committee and several other professional and business organizations, and is active as a consultant to several international organizations. He is the recipient of several national competitive grants and awards for his teaching and research, including the National Science Foundation, is the only faculty recipient of both his school’s Excellence in Research and Excellence in Teaching awards, and is currently the first Board of Visitors Faculty Fellow. Prior to academe, Dr. Beltramini worked for Texas Instruments, Inc. and The Drawing Board, Inc., both in Dallas, and he has also worked as a Visiting Research Professor for J. Walter Thompson Advertising in Chicago, Honeywell Information Systems in Phoenix, and the Federal Trade Commission in Washington, D.C.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beltramini, R.F. Consumer Believability of Information in Direct-to-Consumer (DTC) Advertising of Prescription Drugs. J Bus Ethics 63, 333–343 (2006). https://doi.org/10.1007/s10551-005-4711-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10551-005-4711-2

Keywords

Navigation